# Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

> **NCT03108456** · NA · UNKNOWN · sponsor: **Abbott Medical Devices** · enrollment: 2005 (actual)

## Conditions studied

- Coronary Artery Disease
- Ischemic Heart Disease
- Non ST Segment Elevation Myocardial Infarction

## Interventions

- **DEVICE:** Orbital Atherectomy
- **DEVICE:** Balloon

## Key facts

- **NCT ID:** NCT03108456
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-27
- **Primary completion:** 2024-06-12
- **Final completion:** 2025-06-12
- **Target enrollment:** 2005 (ACTUAL)
- **Last updated:** 2023-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108456, "Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03108456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*